Dorama Dry Aid Eye Drops
NDC Package 49873-503-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dorama Dry Aid Eye Drops is a . Marketed by Sato Pharmaceutical Co., Ltd., this product is identified by NDC 49873-503 and is authorized under FDA application M018.

Identification & Billing

NDC Package Code
49873-503-01
Package Description
1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER
Product Code
49873-503
11-Digit Billing Format
49873050301

Clinical Specifications

Proprietary Name
Dorama Dry Aid Eye Drops
Dosage Form
-

Regulatory & Marketing

Labeler Name
Sato Pharmaceutical Co., Ltd.
FDA Application #
M018
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-13-2022
End Marketing Date
06-30-2025
Listing Expiration
06-30-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49873-503-01 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 15 ml in 1 bottle, dropper of Dorama Dry Aid Eye Drops, labeled by Sato Pharmaceutical Co., Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sato Pharmaceutical Co., Ltd. on January 13, 2022. The current certification is valid through June 30, 2025.

How is this Sato Pharmaceutical Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49873050301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49873-503-01
11-Digit CMS (5-4-2)
49873-0503-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.